Paracetamol Poisoning: Epidemiology, Diagnosis, Treatment (Status of the Issue)
https://doi.org/10.52420/umj.23.6.108
EDN: VCTFHD
Abstract
Introduction. Paracetamol (acetaminophen) is an over-the-counter analgesic and antipyretic drug, available in monoform and included in more than 200 combined drugs. Today, paracetamol is widely used in medicine, and therefore available in different age categories, including children from 0 to 18 years old, adults, the elderly and pregnant women.
The aim is to systematize data on the epidemiology, diagnosis and treatment of paracetamol poisoning based on data from foreign and domestic literature.
Materials and methods. Literary search on the platforms PubMed, Google Scholar, eLibrary.ru, CyberLeninka by keywords “paracetamol, acetaminophen, poisoning, epidemiology, hepatotoxicity, N-acetylcysteine”. Inclusion criteria: original, review articles, randomized and non-randomized clinical trials, meta-analyses and systematic reviews on the topic of paracetamol poisoning.
Results and discussion. The literature review presents data on toxic effects, epidemiology, metabolism, and clinical picture; modern research on methods of diagnosis and treatment of paracetamol poisoning.
Conclusions. Modern methods of diagnosing paracetamol poisoning allow us to focus not only on determining the concentration of the drug in the blood or the dose taken orally, as a decision-making tool. The development of new biomarkers of liver damage is a promising diagnostic tool, suggesting an “early warning” of potential liver damage.
About the Authors
V. G. Sentsov
Ural State Medical University; Sverdlovsk Regional Clinical Psychiatric Hospital
Russian Federation
Competing Interests:
Russian Federation
Valentin G. Sentsov — Doctor of Science (Medicine), Professor, Professor of the Department of Anesthesiology, Resuscitation, Toxicology, Ural State Medical University; Toxicologist, Regional Center for Acute Poisoning, Sverdlovsk Regional Clinical Psychiatric Hospital
Ekaterinburg
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest.
K. Yu. Gusev
Ural State Medical University
Russian Federation
Competing Interests:
Russian Federation
Kirill Yu. Gusev — Assistant of the Department of Anesthesiology, Resuscitation, Toxicology
Ekaterinburg
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest.
N. S. Davydova
Ural State Medical University
Russian Federation
Competing Interests:
Russian Federation
Nadezhda S. Davydova — Doctor of Science (Medicine), Professor, Professor of the Department of Anesthesiology, Resuscitation, Toxicology
Ekaterinburg
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest.
A. V. Chekmarev
Sverdlovsk Regional Clinical Psychiatric Hospital
Russian Federation
Competing Interests:
Russian Federation
Andrey V. Chekmarev — Head of the Intensive Care Unit, Regional Center for Acute Poisoning
Ekaterinburg
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest.
References
1. Athersuch TJ, Antoine DJ, Boobis AR, Coen M, Daly AK, Possamai L, et al. Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: A perspective. Toxicology Research. 2018;7(3):347–357. DOI: https://doi.org/10.1039/c7tx00340d.
2. Bateman DN. Changing the management of paracetamol poisoning. Clinical Therapeutics. 2015;37(9):2135– 2141. DOI: https://doi.org/10.1016/j.clinthera.2015.07.012.
3. Brodie BB, Axelrod J. The fate of acetanilide in man. The Journal of Pharmacology and Experimental Therapeutics. 1948;94(1):29–38. Available from: https://clck.ru/3E7D5z [accessed 22 March 2024].
4. Zotov PB, Lyubov EB, Abuzarova GR, Scriabin EG, Klyashev SM, Petrov VG. Paracetamol among the means of suicidal actions in Russia and abroad. Suicidology. 2019;10(4):99–119. (In Russ). DOI: https://doi.org/10.32878/suiciderus.19-10-04(37)-99-119.
5. Kanabar DJ. A clinical and safety review of paracetamol and ibuprofen in children. Inflammopharmacology. 2017;25(1):1–9. DOI: https://doi.org/10.1007/s10787-016-0302-3.
6. Nilsen K, Staff AC, Krogsrud SK. Paracetamol use in pregnancy: Not as safe as we may think? Acta Obstetricia et Gyneclogica Scandinavica. 2023;102(6):652–656. DOI: https://doi.org/10.1111/aogs.14557.
7. Bauer AZ, Swan SH, Kriebel D, Liew Z, Taylor HS, Bornehag CG, et al. Paracetamol use during pregnancy — a call for precautionary action. Nature Reviews Endocrinology. 2021;17(12):757–766. DOI: https://doi.org/10.1038/s41574-021-00553-7.
8. Alwan S, Conover EA, Harris-Sagaribay L, Lamm SH, Lavigne SV, Lusskin SI, et al. Paracetamol use in pregnancy — caution over causal inference from available data. Nature Reviews Endocrinology. 2022;18(3):190. DOI: https://doi.org/10.1038/s41574-021-00606-x.
9. Savustyanenko AV. The intravenous form of paracetamol: Experience of the world clinics over the past 5 years. Emergency Medicine. 2014;(7):37–44. (In Russ.). EDN: https://elibrary.ru/rzeodc.
10. Kogonia LM, Novikov GA, Orlova RV, Sidorov AV. Practical recommendations for the treatment of chronic pain syndrome in cancer patients. Malignant tumors: Practical recommendations of RUSSCO #3s2. Malignant Tumours. 2018;8(3S2):617–635. (In Russ.). EDN: https://elibrary.ru/heggnc.
11. Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database of Systematic Reviews. 2020;1(1):CD010061. DOI: https://doi.org/10.1002/14651858.CD010061.pub4.
12. Pyregov AV, Ostrik KA. Anesthesiological provision of open fetal surgery. Messenger of Anesthesiology and Resuscitation. 2021;18(5):82–88. (In Russ.). DOI: https://doi.org/10.21292/2078-5658-2021-18-5-82-88.
13. Wong A, Graudins A. Risk prediction of hepatotoxicity in paracetamol poisoning. Clinical Toxicology. 2017;55(8):879–892. DOI: https://doi.org/10.1080/15563650.2017.1317349.
14. Budnitz DS, Lovegrove MC, Crosby AE. Emergency department visits for overdoses of acetaminophen-containing products. American Journal of Preventive Medicine. 2011;40(6):585–592. DOI: https://doi.org/10.1016/j.amepre.2011.02.026.
15. Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, et al. 2020 Annual report of the American association of poison control centers’ National Poison Data System (NPDS): 38th annual report. Clinical Toxicology. 2021;59(12):1282–1501. DOI: https://doi.org/10.1080/15563650.2021.1989785.
16. Dart RC, Mullins ME, Matoushek T, Ruha AM, Burns MM, Simone K, et al. Management of acetaminophen poisoning in the US and Canada: A consensus statement. JAMA Network Open. 2023;6(8):e2327739. DOI: https://doi.org/10.1001/jamanetworkopen.2023.27739.
17. Dewanjee S, Dua TK, Paul P, Dey A, Vallamkondu J, Samanta S, et al. Probiotics: Evolving as a potential therapeutic option against acetaminophen-induced hepatotoxicity. Biomedicines. 2022;10(7):1498. DOI: https://doi.org/10.3390/biomedicines10071498.
18. Wong A, Isbister G, McNulty R, Isoardi K, Harris K, Chiew A, et al. Efficacy of a two bag acetylcysteine regimen to treat paracetamol overdose (2NAC study). eClinicalMedicine. 2020;20:100288. DOI: https://doi.org/10.1016/j.eclinm.2020.100288.
19. Sanhueza-Aroca T, Verdugo-Silva S, Olate-Fica E, Rivas L, Müller-Ramírez C. Acetaminophen poisonings in Chilean healthcare settings: A 20-year story that does not end. Nepal Journal of Epidemiology. 2021; 11(4):1086–1094. DOI: https://doi.org/10.3126/nje.v11i4.38919.
20. Bishop M, Schumann JL, Gerostamoulos D, Wong A. The impact of codeine upscheduling on overdoses, Emergency Department presentations and mortality in Victoria, Australia. Drug and Alcohol Dependence. 2021;226:108837. DOI: https://doi.org/10.1016/j.drugalcdep.2021.108837.
21. Tong HY, Medrano N, Borobia AM, Ruiz JA, Martínez AM, Martín J, et al. Hepatotoxicity induced by acute and chronic paracetamol overdose in children: Where do we stand? World Journal of Pediatrics. 2017; 13(1):76–83. DOI: https://doi.org/10.1007/s12519-016-0046-6.
22. Alonso EM, James LP, Zhang S, Squires RH; Pediatric Acute Liver Failure Study Group. Acetaminophen adducts detected in serum of pediatric patients with acute liver failure. Journal of Pediatric Gastroenterology and Nutrition. 2015;61(1):102–107. DOI: https://doi.org/10.1097/MPG.0000000000000814.
23. Saviuc P, Danel V, Zobnin YV. Acute acetaminophen overdose: The urgent first aid. Siberian Medical Journal. 2008;81(6):107–112. (In Russ.). EDN: https://elibrary.ru/jwbtfn.
24. Chomchai S, Mekavuthikul P, Phuditshinnapatra J, Chomchai C. Sensitivity of dose‐estimations for acute acetaminophen overdose in predicting hepatotoxicity risk using the Rumack‐Matthew Nomogram. Pharmacology Research and Perspectives. 2022;10(1): e00920. DOI: https://doi.org/10.1002/prp2.920.
25. Caparrotta TM, Antoine DJ, Dear JW. Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature. European Journal of Clinical Pharmacology. 2018;74:147–160. DOI: https://doi.org/10.1007/s00228-017-2356-6.
26. Bateman DN, Dear JW. Acetylcysteine in paracetamol poisoning: A perspective of 45 years of use. Toxicology Research. 2019;8(4):489–498. DOI: https://doi.org/10.1039/c9tx00002j.
27. Kovalenko LA, Ipatova MG, Dolginov DM, Afukov II. Acute paracetamol (acetaminophen) poisoning in children. E`ffektivnaya Farmakoterapiya. 2018;32:14–18. (In Russ.). EDN: https://elibrary.ru/sjvpct.
28. Pingili RB, Vemulapalli S, Gadamsetty MVVN, Presingu D, Katuri R, Rachamsetty V, et al. Chlorzoxazone reduced the paracetamol-induced toxicity via competitive inhibition of CYP2E1-mediated metabolism. Future Journal of Pharmaceutical Sciences. 2023;9:34. DOI: https://doi.org/10.1186/s43094-023-00484-2.
29. Nash E, Sabih AH, Chetwood J, Wood G, Pandya K, Yip T, et al. Drug-induced liver injury in Australia, 2009–2020: The increasing proportion of non-paracetamol cases linked with herbal and dietary supplements. The Medical Journal of Australia. 2021;215(6):261–268. DOI: https://doi.org/10.5694/mja2.51173.
30. Li Q, Chen F, Wang F. The immunological mechanisms and therapeutic potential in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity. Cell & Bioscience. 2022;12(1):187. DOI: https://doi.org/10.1186/s13578-022-00921-4.
31. Tasnim F, Huang X, Lee CZW, Ginhoux F, Yu H. Recent advances in models of immune-mediated drug-induced liver injury. Frontiers in Toxicology. 2021;3:605392. DOI: https://doi.org/10.3389/ſtox. 2021.605392.
32. Ye H, Nelson LJ, Gómez del Moral M, Martínez-Naves E, Cubero FJ. Dissecting the molecular pathophysiology of drug-induced liver injury. World Journal of Gastroenterology. 2018;24(13):1373–1385. DOI: https://doi.org/10.3748/wjg.v24.i13.1373.
33. Ramachandran A, Jaeschke H. Acetaminophen hepatotoxicity. Seminars in Liver Disease. 2019;39(2):221– 234. DOI: https://doi.org/10.1055/s-0039-1679919.
34. Noghrehchi F, Cairns R, Buckley NA. Hospital admissions for paracetamol poisoning declined following codeine re-scheduling in Australia. The International Journal of Drug Policy. 2023;116:104040. DOI: https://doi.org/10.1016/j.drugpo.2023.104040.
35. Offor SJ, Amadi CN, Chijioke-Nwauche I, Manautou JE, Orisakwe OE. Potential deleterious effects of paracetamol dose regime used in Nigeria versus that of the United States of America. Toxicology Reports. 2022;9:1035–1044. DOI: https://doi.org/10.1016/j.toxrep.2022.04.025.
36. Simonova AYu, Potskhveriya MM, Belova MV, Ilyashenko KK, Stolbova NE, Kurilkin YuA. Modification of antidote therapy for poisoning due to massive admission of paracetamol. Transplantologiya. The Russian Journal of Transplantation. 2022;14 (4):444–451. (In Russ.). DOI: https://doi.org/10.23873/2074-0506-2022-14-4-444-451.
37. Gosselin S, Juurlink DN, Kielstein JT, Ghannoum M, Lavergne V, Nolin TD, et al. Extracorporeal treatment for acetaminophen poisoning: Recommendations from the EXTRIP workgroup. Clinical Toxicology. 2014; 52(8):856–867. DOI: https://doi.org/10.3109/15563650.2014.946994.
38. Chiew AL, Isbister GK, Kirby KA, Page CB, Chan BSH, Buckley NA. Massive paracetamol overdose: An observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clinical Toxicology. 2017;55(10):1055–1065. DOI: https://doi.org/10.1080/15563650.2017.1334915.
39. Matkevich VA, Potskhveriya MM, Goldfarb YuS, Simonova AYu. Violations of homeostasis parameters in acute poisonings and ways of their correction. Toxicological Review. 2018;(3):18–26. (In Russ.). EDN: https://www.elibrary.ru/xqjldf.
40. Khan Z, Abumedian M, Ibekwe M, Musa K, Mlawa G. Acute renal impairment in patients due to paracetamol overdose in the absence of hepatic impairment. Cureus. 2021;13(12):e20727. DOI: https://doi.org/10.7759/cureus.20727.
41. Rosinha I, Machado M, Cordinhã C, Carmo CD, Gomes C. Paracetamol poisoning: need to remember nephrotoxicity. International Journal of Pediatric Research. 2022;8(1):094. DOI: https://doi.org/10.23937/2469-5769/1510094.
42. Kanchanasurakit S, Arsu A, Siriplabpla W, Duangjai A, Saokaew S. Acetaminophen use and risk of renal impairment: A systematic review and meta-analysis. Kidney Research and Clinical Practice. 2020;39(1):81–92. DOI: https://doi.org/10.23876/j.krcp.19.106.
43. Hadem J, Kielstein JT, Manns MP, Kümpers P, Lukasz A. Outcomes of renal dysfunction in patients with acute liver failure. United European Gastroenterology Journal. 2019;7(3):388–396. DOI: https://doi.org/10.1177/2050640618817061.
44. Petejova N, Martinek A, Zadrazil J, Teplan V. Acute toxic kidney injury. Renal Failure. 2019;41(1):576–594. DOI: https://doi.org/10.1080/0886022X.2019.1628780.
45. Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: A comprehensive update. Journal of Clinical and Translational Hepatology. 2016;4(2):131–142. DOI: https://doi.org/10.14218/JCTH.2015.00052.
46. Yakupova TG, Mukhammadiyeva GF, Karimov DO, Kutlina EG, Bakirov AB, Valova YaV, et al. Transcriptional activity of glutathione system genes in toxic hepatitis caused by paracetamol. Experimental and Clinical Gastroenterology. 2020;174(4):121–127. (In Russ.). DOI: https://doi.org/10.31146/1682-8658-ecg-176-4-121-127.
47. Jepps TA, Dannesboe J, Bastrup J, Hawkins CL. Identifying the mechanism underlying iatrogenic intravenous paracetamol-induced hypotension. The Journal of Pharmacology and Experimental Therapeutics. 2023;385(S3):591. DOI: https://doi.org/10.1124/jpet.122.258300.
48. van der Horst J, Manville RW, Hayes K, Thomsen MB, Abbott GW, Jepps TA. Acetaminophen (paracetamol) metabolites induce vasodilation and hypotension by activating Kv7 potassium channels directly and indirectly. Arteriosclerosis, Thrombosis, and Vascular Biology. 2020;40(5):1207–1219. DOI: https://doi.org/10.1161/ATVBAHA.120.313997.
49. Shifman YeM, Yershov AL. Paracetamol: Therapeutic use and the problem of acute intoxications. General Reanimatology. 2007;3(1):57–65. (In Russ.). EDN: https://elibrary.ru/ibwetf.
50. Antoine DJ, Dear JW. How to treat paracetamol overdose and when to do it. Expert Review of Clinical Pharmacology. 2016;9(5):633–635. DOI: https://doi.org/10.1586/17512433.2016.1154786.
51. Prescott LF, Roscoe P, Wright N, Brown SS. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. The Lancet. 1971;(7698):519–522. DOI: https://doi.org/10.1016/S0140-6736(71)91125-1.
52. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Paediatrics. 1975;55(6):871–876. DOI: https://doi.org/10.1542/peds.55.6.871.
53. Kirschner RI, Rozier CM, Smith LM, Jacobitz KL. Nomogram line crossing aſter acetaminophen combination product overdose. Clinical Toxicology. 2016;54(1):40–46. DOI: https://doi.org/10.3109/15563650.2015.1110591.
54. Kaiser S, Spyker D, Hoyte C, Dart R, Rumack B, Yarema M. 383 What aminotransferase values are clinically important aſter acetaminophen poisoning? Annals of Emergency Medicine. 2022;80(4):S166. DOI: https://doi.org/10.1016/j.annemergmed.2022.08.410.
55. Thompson G, Fatima SB, Shah N, Kitching G, Waring WS. Impact of amending the acetylcysteine marketing authorisation on treatment of paracetamol overdose. International Scholarly Research Notices. 2013;2013:494357. DOI: https://doi.org/10.1155/2013/494357.
56. Spyker DA, Dart RC, Yip L, Reynolds K, Brittain S, Yarema M. Population pharmacokinetic analysis of acetaminophen overdose with immediate release, extended release and modified release formulations. Clinical Toxicology. 2022;60(10):1113–1121. DOI: https://doi.org/10.1080/15563650.2022.2114361.
57. Pedre B, Barayeu U, Ezeriņa D, Dick TP. The mechanism of action of N-acetylcysteine (NAC): The emerging role of H2S and sulfane sulfur species. Pharmacology and Therapeutics. 2021;228:107916. DOI: https://doi.org/10.1016/j.pharmthera.2021.107916.
58. McGovern AJ, Vitkovitsky IV, Jones DL, Mullins ME. Can AST/ALT ratio indicate recovery aſter acute paracetamol poisoning? Clinical Toxicology. 2015;53(3):164–167. DOI: https://doi.org/10.3109/15563650. 2015.1006399.
59. Chiew AL, Gluud C, Brok J, Buckley NA. Interventions for paracetamol (acetaminophen) overdose. The Cochrane Database of Systematic Reviews. 2018;2(2):CD003328. DOI: https://doi.org/10.1002/14651858.CD003328.pub3.
60. Rumack BH. Acetaminophen hepatotoxicity: The first 35 years. Journal of Toxicology: Clinical Toxicology. 2002;40(1):3–20. DOI: https://doi.org/10.1081/CLT-120002882.
61. Simonova AYu, Potskhveriya MM, Belova MV, Ilyashenko KK, Kulabuhov VV, Asanova LR. Comparative evaluation of the effectiveness and safety of 12-hour and 21-hour protocols for the administration of acetylcysteine in paracetamol poisoning. Messenger of Anesthesiology and Resuscitation. 2023;20(4):46–53. (In Russ.). DOI: https://doi.org/10.24884/2078-5658-2022-20-4-46-53.
62. Cairney DG, Beckwith HK, Al-Hourani K, Eddleston M, Bateman DN, Dear JW. Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine. Clinical Toxicology. 2016;54(5):405–410. DOI: https://doi.org/10.3109/15563650.2016.1159309.
63. Fathelrahman AI. Ten challenges associated with management of paracetamol overdose: An update on current practice and relevant evidence from epidemiological and clinical studies. Journal of Clinical and Diagnostic Research. 2021;15(3):FE1–FE6. DOI: https://doi.org/10.7860/JCDR/2021/48219.14580.
64. Dear JW, Antoine DJ, Starkey-Lewis P, Goldring CE, Park BK. Early detection of paracetamol toxicity using circulating liver microRNA and markers of cell necrosis. British Journal of Clinical Pharmacology. 2014; 77(5):904–905. DOI: https://doi.org/10.1111/bcp.12214.
65. Wong A, Nejad C, Gantier M, Choy KW, Doery J, Graudins A. MicroRNA from a 12-h versus 20-h acetylcysteine infusion for paracetamol overdose. Human and Experimental Toxicology. 2019;38(6):646–654. DOI: https://doi.org/10.1177/0960327119833740.
66. Dear JW, Clarke JI, Francis B, Allen L, Wraight J, Shen J, et al. Risk stratification aſter paracetamol overdose using mechanistic biomarkers: Results from two prospective cohort studies. The Lancet. Gastroenterology and Hepatology. 2018;3(2):104–113. DOI: https://doi.org/10.1016/S2468-1253-(17)30266-2.
67. Thulin P, Nordahl G, Gry M, Yimer G, Aklillu E, Makonnen E, et al. Keratin-18 and microRNA-122 compliment alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts. Liver International. 2014;34(3):367–378. DOI: https://doi.org/10.1111/liv.12322.
68. Wong A, Cheung B, Nejad C, Gantier M, Graudins A. Hepatotoxicity aſter paracetamol overdose in a patient with cystic fibrosis despite early acetylcysteine and utility of microRNA to predict hepatotoxicity. Clinical Toxicology. 2018;56(10):904–906. DOI: https://doi.org/10.1080/15563650.2018.1454596.
69. Papageorgiou I, Freytsis M, Court MH. Transcriptome association analysis identifies miR-375 as a major determinant of variable acetaminophen glucuronidation by human liver. Biochemical Pharmacology. 2016;117:78–87. DOI: https://doi.org/10.1016/j.bcp.2016.08.014.
70. Yang X, Salminen WF, Shi Q, Greenhow J, Jill PS, Bhattacharya S, et al. The potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children. Toxicology and Applied Pharmacology. 2015;284(2):180–187. DOI: https://doi.org/10.1016/j.taap.2015.02.013.
71. Simonova AYu, Potskhveriya MM, Belova MV, Ilyashenko KK, Kulabuhov VV, Stolbova NY, et al. On the treatment of acute poisoning with paracetamol. Russian Sklifosovsky Journal “Emergency Medical Care”. 2022;11(2):249–257. (In Russ.). DOI: https://doi.org/10.23934/2223-9022-2022-11-2-249-257.
72. Chiu MH, Jaworska N, Li NL, Yarema M. Massive acetaminophen overdose treated successfully with N‐ acetylcysteine, fomepizole, and hemodialysis. Case Reports in Critical Care. 2021;2021(1):6695967. DOI: https://doi.org/10.1155/2021/6695967.
73. Abdullah-Al-Shoeb M, Sasaki K, Kikutani S, Namba N, Ueno K, Kondo Y, et al. The late-stage protective effect of Mito-TEMPO against acetaminophen-induced hepatotoxicity in mouse and three-dimensional cell culture models. Antioxidants. 2020;9(10):965. DOI: https://doi.org/10.3390/antiox9100965.
74. Nguyen NT, Du K, Akakpo JY, Umbaugh DS, Jaeschke H, Ramachandran A. Mitochondrial protein adduct and superoxide generation are prerequisites for early activation of c-jun N-terminal kinase within the cytosol aſter an acetaminophen overdose in mice. Toxicology Letters. 2021;338:21–31. DOI: https://doi.org/10.1016/j.toxlet.2020.12.005.
75. Jaeschke H. Emerging novel therapies against paracetamol (acetaminophen) hepatotoxicity. eBioMedicine. 2019;46:9–10. DOI: https://doi.org/10.1016/j.ebiom.2019.07.054.
76. Tripathi SS, Singh S, Garg G, Kumar R, Verma AK, Singh AK, et al. Metformin ameliorates acetaminophen- induced sub-acute toxicity via antioxidant property. Drug and Chemical Toxicology. 2019;45(1):52–60. DOI: https://doi.org/10.1080/01480545.2019.1658769.
77. Saeedi Saravi SS, Hasanvand A, Shahkarami K, Dehpour AR. The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB/C mice. Pharmaceutical Biology. 2016;54(12):2830–2837. DOI: https://doi.org/10.1080/13880209.2016.1185633.
78. Wang Y, Lai R, Zong P, Xu Q, Shang J, Zhang X, et al. Bicyclol for the treatment of drug-induced liver injury: A propensity score matching analysis using a nationwide inpatient database. The Journal of International Medical Research. 2021;49(4):3000605211005945. DOI: https://doi.org/10.1177/03000605211005945.
79. Zhao TM, Wang Y, Deng Y, Fan XF, CaoXC, Hou LJ, et al. Bicyclol attenuates acute liver injury by activating autophagy, anti-oxidative and anti-inflammatory capabilities in mice. Frontiers in Pharmacology. 2020;11:463. DOI: https://doi.org/10.3389/fphar.2020.00463.
80. Zhao T, Mao L, Yu Z, Hui Y, Feng H, Wang X, et al. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine. InternationalImmunopharmacology. 2021;91:107308. DOI: https://doi.org/10.1016/j.intimp.2020.107308.
81. Benić MS, Nežić L, Vujić-Aleksić V, Mititelu-Tartau L. Novel therapies for the treatment of drug-induced liver injury: A systematic review. Frontiers in Pharmacology. 2022;12:785790. DOI: https://doi.org/10.3389/fphar.2021.785790.
82. Pettie JM, Caparrotta TM, Hunter RW, Morrison EE, Wood DM, Dargan PI, et al. Safety and efficacy of the SNAP 12-hour acetylcysteine regimen for the treatment of paracetamol overdose. eClinicalMedicine. 2019;11:11–17. DOI: https://doi.org/10.1016/j.eclinm.2019.04.005.
83. Pakravan N, Simpson KJ, Waring WS, Bates CM, Bateman DN. Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit. European Journal of Clinical Pharmacology. 2009;65(2):163–168. DOI: https://doi.org/10.1007/s00228-008-0580-9.
84. Green TJ, Sivilotti ML, Langmann C, Yarema M, Juurlink D, Burns MJ, et al. When do the aminotransferases rise aſter acute acetaminophen overdose? Clinical Toxicology. 2010;48(8):787–792. DOI: https://doi.org/10. 3109/15563650.2010.523828.
85. Sivilotti ML, Good AM, Yarema MC, Juurlink DN, Johnson DW. A new predictor of toxicity following acetaminophen overdose based on pretreatment exposure. Clinical Toxicology. 2005;43(4):229–234. DOI: https://doi.org/10.1081/CLT-66056.
86. Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology. 2013;58(2):777–787. DOI: https://doi.org/10.1002/hep.26294.
Supplementary files
Review
For citations:
Sentsov VG, Gusev KY, Davydova NS, Chekmarev AV. Paracetamol Poisoning: Epidemiology, Diagnosis, Treatment (Status of the Issue). Ural Medical Journal. 2024;23(6):108–131. (In Russ.) https://doi.org/10.52420/umj.23.6.108. EDN: VCTFHD
Views:
438
Email this article 